Iota variant,[1] also known aslineage B.1.526, is one of thevariants ofSARS-CoV-2, the virus that causesCOVID-19. It was first detected inNew York City in November 2020. The variant has appeared with two notable mutations: the E484K spike mutation, which may help the virus evade antibodies, and the S477N mutation, which helps the virus bind more tightly to human cells.[2]
By February 2021, it had spread rapidly in the New York region and accounted for about one in four viral sequences.[3][4] By 11 April 2021, the variant had been detected in at least 48 U.S. states and 18 countries.[5][6]
Under the simplified naming scheme proposed by theWorld Health Organization, B.1.526 has been labeledIota variant, and is considered avariant of interest (VOI), but not yet avariant of concern.[7]
The Iota (B.1.526) genome contains the following amino-acid mutations, all of which are in the virus'sspike protein code: L5F, T95I, D253G, E484K, D614G and A701V.[8]
Amino acid mutations of SARS-CoV-2 Iota variant plotted on a genome map of SARS-CoV-2 with a focus on the spike.[9]
The increase of the Iota variant was captured by researchers atCaltech by scanning for mutations in a database known asGISAID, a global science initiative that has documented over 700,000 genomic sequences of SARS-CoV-2.[10][11]
The proportion of USA cases represented by the Iota variant had declined sharply by the end of July 2021 as theDelta variant became dominant.[12]